The JPIAMR Steering Committee (SC) provides steering direction of the JPIAMR and strategic input to undertake the JPIAMR mission. The SC meets regularly to discuss strategic issues, develop proposals for the MB and follows the implementation of activities by the JPIAMR Secretariat.
Steering Committee Members
Jan-Ingvar Jönsson, Sweden, Chair
Jan-Ingvar Jönsson is Vice-Chancellor and Professor at Linköping University in Sweden. He was member of the Scientific Council for Medicine and Health at the Swedish Research Council during the period 2013-2015, and from 2016 until the summer of 2020 he was secretary general of the Swedish Research Council, with scientific responsibility for medicine and health. Prof. Jönsson holds several national commissions, and in 2017 he was appointed to lead the newly established National research programme in antibiotic resistance in Sweden. He is national representative of several international organisations and is since 2019 chair of JPIAMR. He is also involved in collaboration between several other research funding agencies and policy makers worldwide.
Dr. Marie-Paule Kieny is Director of Research at Inserm in Paris, in charge of the Priority Research Program on Antibiotic Resistance initiated by France in 2019 as part of the Investment Program for the Future (Programme d’Investissements d’Avenir). Dr. Kieny is Chair of the Board of Directors of the Drugs for Neglected Diseases Initiative (DNDi, Geneva, Switzerland) and of the Medicines Patent Pool Foundation (MPPF, Geneva, Switzerland). She is also Vice-Chair of the Board of the Global Antibiotic Research and Development Partnership (GARDP, Geneva, Switzerland), member of the Board of Directors of the Human Vaccine Project (HVP, New York, USA), of Fondation Mérieux (Lyon, France) and of the association Solidarité Thérapeutique et Initiatives pour la Santé (Solthis, Paris, France). She is an independent nonexecutive Director of bioMérieux (Lyon, France). She participates in the scientific councils of several organizations active in the field of health.
Charu Kaushic, Canada
Dr. Charu Kaushic is the Scientific Director of the Canadian Institutes of Health Research (CIHR)-Institute of Infection and Immunity, serving in this role since July 1, 2018. Dr. Kaushic is also a tenured Full Professor in the Department of Pathology and Molecular Medicine in McMaster University, Hamilton, Canada. In her role as the Scientific Director for CIHR-III, Dr. Kaushic is responsible for making decisions for CIHR strategic investments in the area of infection and immunity nationally and internationally. She also represents CIHR and Government of Canada at various national and international forums related to infectious diseases. In this capacity she serves as a Co-Chair of GloPID-R, a global consortium of funders in pandemic preparedness and emergency response research. She also represents Canada on the JPIAMR Management Board.
Joachim Klein, Germany
Dr Joachim Klein has worked for the German Federal Ministry of Education and Research (BMBF) since 2008 in the divisions “Strategy and Policy Issues of the Life Sciences” and “Health Research”. Before, he was in the management team of a biotech company and responsible for business development and scientific coordination. Dr Klein has a doctorate in biology and currently serves as Deputy Head of Division “Global Health Research” where he is responsible for several BMBF funding programs. He represents the BMBF in the board of trustees of the Bernhard Nocht Institute for Tropical Medicine, the Leibniz Institute for Natural Product Research and Infection Biology and in the board of the Coalition for Epidemic Preparedness Innovations (CEPI).
Richard Gordon, South Africa
Dr. Richard Gordon is the Executive Director of the Grants, Innovation and Product Development groups at the South African Medical Research Council (SAMRC). The unit manages more than 200 grants ranging from small independent research awards to major international programs seeking to develop new drugs vaccines and medical devices. It is the largest African based funder of Research. The majority of the SAMRC programs focus on HIV, Tuberculosis and Malaria – including drug resistance. Collaboration partners include: GARD-P, the WHO, the Bill and Melinda Gates Foundation, The UK Newton Fund and several others. Dr. Gordon has held a number of international positions and specializes in establishing international research partnerships. These range from drug discovery (target discovery, high throughput screening, medicinal chemistry, ADMET and pharmacology for a wide range of therapeutic areas), medical devices and vaccines.
Dr. Jonathan Pearce joined the Medical Research Council in 2008. Prior to this Jonathan undertook academic research at Cambridge, Oxford and Toronto, followed by roles in life sciences venture capital and strategic consulting. Dr. Pearce is now Interim Director, Covid-19 Response, and in his time at MRC has served as Associate Director for Biological Medicine and has had responsibility for Infections and Immunity, including Chairing the £85m UKRI AMR initiative and the UK AMR Funders Forum, led the Council’s £60 million precision medicine initiative, and established the Council’s translational research funding scheme, the DPFS. He also represents the MRC on the Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R) network.